Specific Tumor Component Spectrum as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

被引：0
|
作者：
Xu, S. [1 ]
Cerussi, A. E. [1 ]
Tromberg, B. [1 ]
Gratton, E. [1 ]
机构：
[1] Univ Calif Irvine, Irvine, CA USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P5-01-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-01-12
引用
收藏
页数：1
相关论文
共 50 条
  • [21] KI67 AS A PREDICTOR OF CLINICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN TRIPLEPOSITIVE BREAST CANCER
    Ben Hamida, Karim
    Houcine, Yoldez
    Maaoui, Amal
    Hamza, Khedija
    Kamoun, Salma
    Ayadi, Senda
    Chargui, Riadh
    Driss, Maha
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A59 - A59
  • [22] Prognostic Significance of Peripheral Blood Parameters as Predictor of Neoadjuvant Chemotherapy Response in Breast Cancer
    Faur, Ionut Flaviu
    Dobrescu, Amadeus
    Clim, Ioana Adelina
    Pasca, Paul
    Burta, Cosmin
    Tarta, Cristi
    Brebu, Dan
    Neamtu, Andreea-Adriana
    Braicu, Vlad
    Duta, Ciprian
    Totolici, Bogdan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [23] Changes in quantitative ultrasound imaging as the predictor of response to neoadjuvant chemotherapy in patients with breast cancer
    Piotrzkowska-Wroblewska, Hanna
    Dobruch-Sobczak, Katarzyna
    Gumowska, Magdalena
    Litniewski, Jerzy
    2022 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IEEE IUS), 2022,
  • [24] Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer
    Jain, Parveen
    Doval, Dinesh Chandra
    Batra, Ullas
    Goyal, Pankaj
    Bothra, Sneha Jatan
    Agarwal, Chaturbhuj
    Choudhary, Dutta Kumardeep
    Yadav, Abhishek
    Koyalla, Venkata Pradeep Babu
    Sharma, Mansi
    Dash, Prashanta
    Talwar, Vineet
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (04) : 329 - 338
  • [25] Identifying dihydrofolate reductase as a predictor for poor response to neoadjuvant chemotherapy in breast cancer patients
    Shi, Tingting
    Tian, Nannan
    Wu, Yueting
    Xu, Lin
    Sun, Weijuan
    Wang, Qiang
    Zhang, Mei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (12): : 13619 - 13626
  • [26] Platelet predominant breast cancer is a new predictor for pathological complete response to neoadjuvant chemotherapy
    Ishikawa, Satoko
    Inokuchi, Masafumi
    Hayashi, Hironori
    Oyama, Katsunobu
    Nakagawara, Hisatoshi
    Miyashita, Tomoharu
    Tajima, Hidehiro
    Takamura, Hiroyuki
    Ninomiya, Itasu
    Kitagawa, Hirohisa
    Fushida, Sachio
    Fujimura, Takashi
    Ohta, Tetsuo
    CANCER RESEARCH, 2015, 75
  • [27] PPAR signaling pathway may be an important predictor of breast cancer response to neoadjuvant chemotherapy
    Chen, Y. Z.
    Xue, J. Y.
    Chen, C. M.
    Yang, B. L.
    Xu, Q. H.
    Wu, F.
    Liu, F.
    Ye, X.
    Meng, X.
    Liu, G. Y.
    Shen, Z. Z.
    Shao, Z. M.
    Wu, J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (05) : 637 - 644
  • [28] The role of taxanes as a component of neoadjuvant chemotherapy for breast cancer
    Gogas, H
    Fountzilas, G
    ANNALS OF ONCOLOGY, 2003, 14 (05) : 667 - 674
  • [29] Tumor-infiltrating lymphocytes are an important pathological predictor for neoadjuvant chemotherapy in patients with breast cancer
    Yamaguchi, R.
    Tanaka, M.
    Yano, A.
    Yamaguchi, M.
    Yano, H.
    BREAST, 2011, 20 : S76 - S76
  • [30] Prediction of neoadjuvant chemotherapy response in breast cancer
    Izquierdo, M.
    Rodriguez, I.
    Tresserra, F.
    Maria, G.
    Baulies, S.
    Ara, C.
    Fabregas, R.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S95 - S95
12345